Legend's new CMO will bring in more cell therapy partners; Precision founders get back in Tune together
Mythili Koneru returned to her childhood stomping grounds of New Jersey last Friday to lead the medical operations at Legend Biotech, where she’ll drive the cell therapy maker’s expansion into solid tumors and off-the-shelf options.
Legend will tap into her business development chops, built during a stint at Eli Lilly, as it looks to ink more partnerships on the back of its successful collaboration with Johnson & Johnson‘s Janssen, which helped solidify the biotech as one of the early leaders in cell therapy with the approval of Carvykti.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters